HAVCR2 and acute lymphoblastic leukemia: Receiver operating characteristic (ROC) curves were built using the TIM-3 gene expression and serum TIM-3 values in patients with malignant B-ALL and non-malignant healthy controls to evaluate the sensitivity and specificity of TIM-3.